Literature DB >> 927538

Glucosidase inhibition. A new approach to the treatment of diabetes, obesity, and hyperlipoproteinaemia.

W Puls, U Keup, H P Krause, G Thomas, F Hoffmeister.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 927538     DOI: 10.1007/bf00483562

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


× No keyword cloud information.
  3 in total

1.  alpha-Glucosidase inhibitors. New complex oligosaccharides of microbial origin.

Authors:  D D Schmidt; W Frommer; B Junge; L Müller; W Wingender; E Truscheit; D Schäfer
Journal:  Naturwissenschaften       Date:  1977-10

2.  Influence of an -amylase inhibitor (BAY d 7791) on blood glucose, serum insulin and NEFA in starch loading tests in rats, dogs and man.

Authors:  W Puls; U Keup
Journal:  Diabetologia       Date:  1973-04       Impact factor: 10.122

3.  Inhibition of sucrase by tris in rat and man, demonstrated by oral loading tests with sucrose.

Authors:  W Puls; U Keup
Journal:  Metabolism       Date:  1975-01       Impact factor: 8.694

  3 in total
  51 in total

1.  [Acarbose for prevention of diabetes mellitus. STOP-NIDDM]].

Authors:  E Windler
Journal:  Internist (Berl)       Date:  2003-04       Impact factor: 0.743

Review 2.  Pharmacokinetic-pharmacodynamic relationships of Acarbose.

Authors:  T Salvatore; D Giugliano
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

3.  Effect of acarbose on carbohydrate tolerance during administration of a fibre-free formula diet on healthy subjects.

Authors:  I E Walter-Sack; A Ittner-Holland; G Wolfram; N Zoellner
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 4.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

5.  Effect of the alpha-glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics.

Authors:  G Sachse; B Willms
Journal:  Diabetologia       Date:  1979-11       Impact factor: 10.122

6.  Effect of alpha-glucosidehydrolase inhibition and intestinal absorption of sucrose, water, and sodium in man.

Authors:  W F Caspary; H Kalisch
Journal:  Gut       Date:  1979-09       Impact factor: 23.059

7.  Glibenclamide pharmacokinetics in acarbose-treated type 2 diabetics.

Authors:  J Gerard; P J Lefebvre; A S Luyckx
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Effects of the alpha-glucosidase inhibitor 1 desoxynojirimycin (Bay m 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients.

Authors:  C Schnack; G Röggla; A Luger; G Schernthaner
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 9.  Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency.

Authors:  A D Harrower
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

10.  d-Psicose Inhibits Intestinal alpha-Glucosidase and Suppresses the Glycemic Response after Ingestion of Carbohydrates in Rats.

Authors:  Tatsuhiro Matsuo; Ken Izumori
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.